What are the considerations for using sertraline (Zoloft), buspirone (Buspar), trazodone, and lamotrigine (Lamictal) during pregnancy?

Pregnancy Considerations for Sertraline (Zoloft), Buspirone (Buspar), Trazodone, and Lamotrigine (Lamictal)

Continue sertraline (Zoloft) during pregnancy if needed for maternal functioning, as the risk of untreated depression outweighs the minimal fetal risks; lamotrigine is safe to continue; avoid trazodone and buspirone due to insufficient safety data.

Sertraline (Zoloft) - SSRI

Sertraline is among the safest antidepressants in pregnancy and should be continued at the lowest effective dose if required for maternal mental health. 1

Key Evidence:

• No increased risk of major birth defects in first trimester exposure based on meta-analyses (odds ratio 1.01 for total malformations, 0.93 for cardiac malformations) 1
• Third trimester exposure may cause neonatal adaptation syndrome in up to 30% of exposed infants, presenting with irritability, jitteriness, tremors, feeding difficulties, respiratory distress, and hypoglycemia 2, 1
  • These symptoms are typically mild and self-limiting, resolving within 1-2 weeks 2
  • Monitor neonates for 48 hours minimum after delivery 3
• Persistent pulmonary hypertension of the newborn (PPHN) shows conflicting evidence, with risk ratio of 2.4-3.6 if used after 20 weeks gestation, but absolute risk remains low (1-2 per 1000 births baseline) 1
• Women who discontinue antidepressants during pregnancy have higher relapse rates of major depression 1

Clinical Management:

• Use the lowest effective dose throughout pregnancy 2
• Do not discontinue abruptly - untreated maternal depression carries risks of preterm birth, decreased breastfeeding initiation, and adverse maternal-infant bonding 4, 1
• Monitor fetal growth, maternal blood pressure, and weight gain 5
• Arrange early neonatal follow-up within 48 hours of discharge to monitor for withdrawal symptoms 2

Breastfeeding:

Sertraline is preferred during breastfeeding with minimal excretion into breast milk (<10% of maternal dose) and low infant plasma concentrations 2, 4

---

Lamotrigine (Lamictal) - Mood Stabilizer

Lamotrigine is one of the safest mood stabilizers in pregnancy and should be continued for seizure control or bipolar disorder. 6, 7

Key Evidence:

• Preferred first-line antiepileptic during pregnancy with the lowest teratogenic risk among mood stabilizers 6, 7
• No significant increase in major congenital malformations compared to unexposed pregnancies 6
• Serum levels may decrease during pregnancy due to increased metabolism - therapeutic drug monitoring is essential 8

Clinical Management:

• Monitor lamotrigine serum levels throughout pregnancy, particularly in second and third trimesters 8
• Dose adjustments are frequently needed as pregnancy progresses due to increased clearance
• Continue at effective dose - do not discontinue as untreated seizures or bipolar disorder pose greater risks to mother and fetus 6, 7

Breastfeeding:

Lamotrigine has high milk/serum penetration ratios but is generally considered compatible with breastfeeding with infant monitoring 8

---

Trazodone - Serotonergic Antidepressant

Avoid trazodone during pregnancy due to insufficient safety data; switch to sertraline if antidepressant treatment is required. 9

Key Evidence:

• No adequate human pregnancy data available for trazodone
• Limited evidence suggests it may be used for migraine in pregnancy under specialist supervision, but this is not a primary indication 9
• Risk of serotonin syndrome when combined with other serotonergic agents (like sertraline), particularly with rapid titration 10

Clinical Management:

• Discontinue before conception if possible
• If patient is stable on trazodone, consider switching to sertraline preconceptionally or early in pregnancy
• If continuation is deemed absolutely necessary, use lowest effective dose with specialist consultation

---

Buspirone (Buspar) - Anxiolytic

Avoid buspirone during pregnancy due to lack of safety data; consider cognitive behavioral therapy or sertraline for anxiety management instead.

Key Evidence:

• No adequate human pregnancy data exists for buspirone
• Not mentioned in major pregnancy guidelines for psychiatric medication
• Insufficient evidence to assess teratogenic risk

Clinical Management:

• Discontinue before conception if possible
• For anxiety management in pregnancy, prioritize:
  1. Cognitive behavioral therapy as first-line 11
  2. Sertraline if pharmacotherapy is required (has anxiety indications and pregnancy safety data)
• Do not initiate buspirone during pregnancy

---

Overall Pregnancy Management Algorithm

Preconception Planning:

1. Continue sertraline and lamotrigine if controlling symptoms
2. Discontinue trazodone and buspirone - switch to sertraline if needed
3. Optimize doses to lowest effective levels
4. Discuss risks/benefits with patient using shared decision-making 1

During Pregnancy:

1. Monitor sertraline and lamotrigine levels - adjust doses as needed 8
2. Monitor fetal growth, maternal BP, and weight gain monthly 5
3. Third trimester: Prepare neonatal team for possible adaptation syndrome with sertraline exposure
4. Consider fetal echocardiography if SSRI exposure after 20 weeks (for PPHN risk assessment)

Delivery and Postpartum:

1. Do not discontinue medications at delivery 1
2. Monitor neonate for 48-72 hours minimum for withdrawal/adaptation symptoms 2, 3
3. Watch for: jitteriness, tremors, irritability, feeding difficulties, respiratory distress, temperature instability
4. Continue breastfeeding with sertraline and lamotrigine - benefits outweigh minimal infant exposure 2, 4, 8

Common Pitfalls:

• Do not discontinue effective psychiatric medications due to pregnancy - untreated maternal illness poses greater risks 1
• Do not use ZOLOFT oral solution during pregnancy (contains 12% alcohol) - use tablets only 1
• Do not confuse neonatal adaptation syndrome with serious pathology - most cases are self-limiting 2
• Do not avoid breastfeeding on sertraline - it is one of the safest options 2, 4